Zeppieri, M.; Gagliano, C.; Tognetto, D.; Musa, M.; Rossi, F.B.; Greggio, A.; Gualandi, G.; Galan, A.; Babighian, S.
Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma. Pharmaceutics 2025, 17, 580.
https://doi.org/10.3390/pharmaceutics17050580
AMA Style
Zeppieri M, Gagliano C, Tognetto D, Musa M, Rossi FB, Greggio A, Gualandi G, Galan A, Babighian S.
Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma. Pharmaceutics. 2025; 17(5):580.
https://doi.org/10.3390/pharmaceutics17050580
Chicago/Turabian Style
Zeppieri, Marco, Caterina Gagliano, Daniele Tognetto, Mutali Musa, Federico Bernardo Rossi, Angelo Greggio, Giuliano Gualandi, Alessandro Galan, and Silvia Babighian.
2025. "Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma" Pharmaceutics 17, no. 5: 580.
https://doi.org/10.3390/pharmaceutics17050580
APA Style
Zeppieri, M., Gagliano, C., Tognetto, D., Musa, M., Rossi, F. B., Greggio, A., Gualandi, G., Galan, A., & Babighian, S.
(2025). Unraveling the Mechanisms, Clinical Impact, Comparisons, and Safety Profiles of Slow-Release Therapies in Glaucoma. Pharmaceutics, 17(5), 580.
https://doi.org/10.3390/pharmaceutics17050580
